BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 34332594)

  • 21. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T; Kawahara Y
    Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
    de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
    Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aicardi-Goutières syndrome: A monogenic type I interferonopathy.
    Liu A; Ying S
    Scand J Immunol; 2023 Oct; 98(4):e13314. PubMed ID: 37515439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
    PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
    Livingston JH; Crow YJ
    Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1.
    Maurano M; Snyder JM; Connelly C; Henao-Mejia J; Sidrauski C; Stetson DB
    Immunity; 2021 Sep; 54(9):1948-1960.e5. PubMed ID: 34343497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate immune activation without immune cell infiltration in brains of murine models of Aicardi-Goutières Syndrome.
    Wiley CA; Steinman RA; Wang Q
    Brain Pathol; 2023 May; 33(3):e13118. PubMed ID: 36161399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restricting retrotransposons: ADAR1 is another guardian of the human genome.
    Orecchini E; Frassinelli L; Michienzi A
    RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
    Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
    Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease.
    Rice GI; Kitabayashi N; Barth M; Briggs TA; Burton ACE; Carpanelli ML; Cerisola AM; Colson C; Dale RC; Danti FR; Darin N; De Azua B; De Giorgis V; De Goede CGL; Desguerre I; De Laet C; Eslahi A; Fahey MC; Fallon P; Fay A; Fazzi E; Gorman MP; Gowrinathan NR; Hully M; Kurian MA; Leboucq N; Lin JS; Lines MA; Mar SS; Maroofian R; Martí-Sanchez L; McCullagh G; Mojarrad M; Narayanan V; Orcesi S; Ortigoza-Escobar JD; Pérez-Dueñas B; Petit F; Ramsey KM; Rasmussen M; Rivier F; Rodríguez-Pombo P; Roubertie A; Stödberg TI; Toosi MB; Toutain A; Uettwiller F; Ulrick N; Vanderver A; Waldman A; Livingston JH; Crow YJ
    Neuropediatrics; 2017 Jun; 48(3):166-184. PubMed ID: 28561207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
    Nakahama T; Kawahara Y
    Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA sensing via the RIG-I-like receptor LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency.
    Stok JE; Oosenbrug T; Ter Haar LR; Gravekamp D; Bromley CP; Zelenay S; Reis e Sousa C; van der Veen AG
    EMBO J; 2022 Mar; 41(6):e109760. PubMed ID: 35156720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of three induced pluripotent stem cell lines from individuals with Aicardi-Goutières syndrome caused by a c.3019G>A (p.G1007R) autosomal dominant pathogenic variant in ADAR1.
    Garcia L; Gonzalez CD; Gagne A; McGuire JA; French D; Takanohashi A; Almad A; Vanderver A; Sase S
    Stem Cell Res; 2024 Feb; 74():103299. PubMed ID: 38181636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytes, an active player in Aicardi-Goutières syndrome.
    Sase S; Takanohashi A; Vanderver A; Almad A
    Brain Pathol; 2018 May; 28(3):399-407. PubMed ID: 29740948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
    Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response.
    Mackenzie KJ; Carroll P; Lettice L; Tarnauskaitė Ž; Reddy K; Dix F; Revuelta A; Abbondati E; Rigby RE; Rabe B; Kilanowski F; Grimes G; Fluteau A; Devenney PS; Hill RE; Reijns MA; Jackson AP
    EMBO J; 2016 Apr; 35(8):831-44. PubMed ID: 26903602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAR1 entraps sinister cellular dsRNAs, thresholding antiviral responses.
    Keegan LP; Vukić D; O'Connell MA
    Trends Immunol; 2021 Nov; 42(11):953-955. PubMed ID: 34642093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.
    Daou S; Talukdar M; Tang J; Dong B; Banerjee S; Li Y; Duffy NM; Ogunjimi AA; Gaughan C; Jha BK; Gish G; Tavernier N; Mao D; Weiss SR; Huang H; Silverman RH; Sicheri F
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24802-24812. PubMed ID: 32958664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon in neurological disease-the devil from within.
    Hofer MJ; Campbell IL
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):257-67. PubMed ID: 23548179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.